Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Drug Saf. 2017 Mar;40(3):263–272. doi: 10.1007/s40264-016-0490-1

Fig 2.

Fig 2

Identification of multiple provider prescribing of interacting drugs, defined as co-prescriptions of interacting drugs by different providers that were repeated more than once, where each episode of co-prescription had an overlapping coverage of more than 14 days